REGENERATE Study Investigators 2019, ' Obeticholic acid for the treatment of non-alcoholic steatohepatitis : interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ', The Lancet, vol. 394, no. 10215, pp. 2184-2196 . https://doi.org/10.1016/S0140-6736(19)33041-7 The lancet : international edition Younossi, Z M, Ratziu, V, Loomba, R, Rinella, M, Anstee, Q M, Goodman, Z, Bedossa, P, Geier, A, Beckebaum, S, Newsome, P N, Sheridan, D, Sheikh, M Y, Trotter, J, Knapple, W, Lawitz, E, Abdelmalek, M F, Kowdley, K V, Montano-Loza, A J, Boursier, J, Mathurin, P, Bugianesi, E, Mazzella, G, Olveira, A, Cortez-Pinto, H, Graupera, I, Orr, D, Gluud, L L, Dufour, J-F, Shapiro, D, Campagna, J, Zaru, L, MacConell, L, Shringarpure, R, Harrison, S, Sanyal, A J & REGENERATE Study Investigators 2019, ' Obeticholic acid for the treatment of non-alcoholic steatohepatitis : interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ', The Lancet, vol. 394, no. 10215, pp. 2184-2196 . https://doi.org/10.1016/S0140-6736(19)33041-7
Christensen, P B, Øvrehus, A L H & The Polaris observatoriy HCV collaborators 2017, ' Global prevalence and genotype distribution of hepatitis C virus infection in 2015 : a modelling study ', The Lancet Gastroenterology & Hepatology, vol. 2, no. 3, pp. 161–176 . https://doi.org/10.1016/S2468-1253(16)30181-9 LANCET GASTROENTEROLOGY & HEPATOLOGY The Lancet Gastroenterology & Hepatology, Vol. 2, No 3 (2017) pp. 161-176 Krarup, H & Polaris Observatory HCV Collaborators 2017, ' Global prevalence and genotype distribution of hepatitis C virus infection in 2015 : a modelling study ', The Lancet Gastroenterology & Hepatology, vol. 2, no. 3, pp. 161-176 . https://doi.org/10.1016/S2468-1253(16)30181-9